1.The X-ray findings of spondylometaphyseal dysplasia
Ze-Kun ZHANG ; Yu-Qing LI ; Jing-Pin ZHAO ; Wen-Juan WU ; Jing GAO ; Bao-Hai YU ; Zhen WANG ;
Chinese Journal of Radiology 2001;0(01):-
Objective To explore the clinical,radiological findings and pathogenic factor of spondylometaphyseal dysplasia.Methods Five cases were reported and the relevant documents were studied retrospectively.Plain X-ray film was performed in all patients.Results There were 4 male and 1 female,age ranged from 4 to 15 years with average of 9 years.The main features of 5 cases included delayed bone age,stature short,short trunk,waddling gait noted,scoliosis in 2 cases,kyphoscoliosis in 1 case,severe genu valgum in 2 cases.The main X-ray appearance of 5 cases is multiple irregularities of long bones metaphyses associated with platyspondylia,epiphysis is normal.Type Ⅰ SMD in 2 cases,Type Ⅱ SMD in 1 case,Type Ⅲ SMD in 2 cases.Conclusion When we meet children with delayed bone age and stature short,and muhiple irregularities of long bones metaphyses associated with platyspondylia were seen in X-ray plain film.we should think about spondylometaphyseal dysplasia.
2.Modified posterior lumbar interbody fusion augmented with bone cement in the treatment of senile degenerative lumbar spondylolisthesis: study protocol for a self-controlled trial
Rong REN ; Qi-Fa GUO ; Zhao-Wei LI ; Ze-Qing LI ; Bao-Ming TANG
Chinese Journal of Tissue Engineering Research 2018;22(15):2350-2354
BACKGROUND: Posterior lumbar interbody fusion is the main repair method for senile degenerative lumbar spondylolisthesis. For elderly patients with osteoporosis, single screw rod system fixation regularly results in dislocation. The incidence of implant loosening is high, and therefore, effective internal fixation is not achieved. OBJECTIVE: This study will use the modified posterior lumbar interbody fusion procedure combined with bone cement augmentation for the treatment of senile degenerative lumbar spondylolisthesis so as to increase the stability of the vertebral body, make the fixator firm, and to maximize the recovery of postoperative motor function. METHODS: Totally 113 patients with senile degenerative lumbar spondylolisthesis, aged 65-70 years, irrespective of sex, will be recruited from the Department of Orthopedics of Affiliated Hospital of Qinghai University of China. The patients will be treated with modified posterior lumbar interbody fusion combined with bone cement augmentation. Follow-up will be performed at 3 and 12 months. The primary outcome measure is recovery of motor function as indicated by the postoperative Oswestry Disability Index score at 12 months. The secondary outcome measures are the change in the rate of excellent and good Oswestry Disability Index scores (comparing preoperative scores with the 4-month postoperative scores), Visual Analogue Scale scores, intervertebral space height, foraminal height, the preoperative and 4 and 14 months postoperative slip distance and slip angle, incidence of adverse reactions, success rate of vertebral fusion, and incidence of secondary slip 4 and 14 months postoperatively. This trial has been approved by the Medical Ethics Committee of Affiliated Hospital of Qinghai University of China(approval number:QHY023G).The study protocol will be proformed in accordance with the Declaration of Helsinki, formulated by the World Medical Association. Written informed consent will be obtained from all participants. This trial was designed in October 2017. The recruitment of subjects and data collection will begin in June 2018. The recruitment will be finished in December 2018. Outcome measures will be analyzed in January 2020. This trial will be completed in February 2020. The results of the trial will be reported in a scientific conference or disseminated in a peer-reviewed journal. This trial had been registered in the Chinese Clinical Trial Registry (registration number: ChiCTR1800015335). Protocol version (1.0). DISCUSSION: This trial aims to observe the efficacy of modified posterior lumbar interbody fusion combined with bone cement augmentation in the treatment of senile degenerative lumbar spondylolisthesis and to validate whether the procedure is safe and reliable.
3.Correlation between calcineurin inhibitor drug-induced chronic nephrotoxicity in patient after kidney allograft and the CYP3A4 * 1G gene polymorphism
Ze-Qing BAO ; Shu-Jin ZHAO ; Yun-Song ZHU ; Lei SHI
The Chinese Journal of Clinical Pharmacology 2017;33(5):401-403
Objective To observe the relationship between CYP3A4 * 1G genetic polymorphism with calcineurin inhibitor(CNI)-induced chronic nphrotoxicity in Chinese population.Methods Blood samples and clinical data were collected from 200 Chinese patients with CNI drug-induced chronic nephrotoxicity as treatment group and 200 Chinese kidney allograft recipients without chronic nephrotoxicity as the control.DNA was extracted from the blood samples of patients in two groups,and the frequencies of CYP3A4 * 1G genotypes were analyzed using polymerase chain reaction-restriction fragment length polymorphism.The relationship between the polymorphisms of CYP3A4 * 1G and the CNI drug-induced chronic nephrotoxicity was analyzed.Results The frequencies of the 3 gene types CYP3A4 * 1G RsaI 1/1,1/1G,and 1G/1G were 51% (102/200),34.5% (69/200) and 14.5% (29/200) respectively in patients with CNI drug-induced chronic nephrotoxicity (treatment group),and49.5% (99/200),45% (90/200),and5.5% (11/200) respectively in the control group.A statistical difference was found between the cases and the control (P < 0.05,OR =2.914,95% CI =1.41-6.01).Conclusion The polymorphism of CYP3A4 * 1 G/* 1G remained a significant independent risk factor for CNIs drug-induced chronic nephrotoxicity after kidney allograft.
4.Effects of valsartan and U0126 on atrial fibrosis and connexin40 remodeling in rats
Wei-Ze ZHANG ; Zhi-Gang WANG ; Yong-Qing CHEN ; Ling MA ; Tao LI ; Hong-Gang BAO ; Pei-Hong LI
Chinese Journal of Cardiology 2011;39(12):1129-1134
Objective To explore the effects of valsartan and MEK1/2 inhibitor U0126 on atrial fibrosis and connexin40 (Cx40) remodeling in rats treated with isopreterenol (ISO).Methods 32 male SD rats were randomly divided into control group (A),ISO (5 mg · kg-1 · d-1 for7 days) + DMSO group (B),ISO + U0126 (0.5 mg · kg-1 · d-1 for 28 days) group (C,U0126 was dissolved in DMSO),ISO +valsartan (30 mg · kg-1 · d-1 for 28 days) + DMSO group (D).Rats were sacrificed after 28 days.The AngⅡ content in myocardial tissue was measured by radioimmunoassay,P-MEK1/2,P-ERK1/2 and Cx40 was detected by immunohistochemistry,atrial fibrosis was determined on HE and Masson stained heart sections.Results The content of Ang Ⅱ was significantly higher in group B,C and D compared with group A [ (368.243 ±6.283 ) ng/L,( 357.175 ± 5.944 ) ng/L,( 359.908 ± 2.496 ) ng/L vs ( 250.380 ± 4.261 )ng/L,P <0.01 ] ; the degree of atrial fibrosis was significantly lower in group C and D compared with group B [CVF(10.260 ±0.525)%,(10.238 ±0.524)% vs (78.710 ± 1.587)%,P<0.01 ] while there was no atrial fibrosis in group A [ CVF(9.025 ± 0.456)% ] ; the expression of P-MEK1/2 and P-ERK1/2 was significantly upregulated in group B compared with group A ( P-MEK1/2:0.311 ± 0.007 vs 0.203 ± 0.009,P <0.01 ; P-ERK1/2:0.259 ±0.003 vs 0.173 ±0.006,P <0.01 ) and significantly lower in group C and D compared with group B (P-MEK1/2:0.212 ± 0.004,0.213 ± 0.005 vs 0.311 ± 0.007,P <0.01,P-ERK1/2:0.178 ±0.004,0.175 ±0.007 vs 0.259 ±0.003,P <0.01 ).The content of Cx40 was obviously reduced and the distribution of Cx40 was disordered in group B compared with A (0.199 ±0.007 vs 0.241 ±0.004,P<0.01) which could be partly reversed in group C and D ( 0.239 ±0.037,0.235 ±0.006 vs 0.199 ± 0.007,P < 0.01 ).All parameters in group C and D were similar ( P > 0.05 ).Conclusion The chronically elevated Ang Ⅱ content in myocardium may be related to atrial fibrosis and Cx40 remodeling in this model,valsartan and U0126 were equivalent on attenuating atrial fibrosis and Cx40 remodeling by inhibiting ERK pathways at different levels.
5.Comparison between genotyping and serological phenotyping in RhCE blood group.
Hua-you ZHOU ; Yin-ze ZHANG ; Qing-bao MENG ; Xu-hua BAI ; Cong-rong WANG ; Qiong CAO ; Jiong-cai LAN
Chinese Journal of Medical Genetics 2008;25(1):66-69
OBJECTIVETo genotype the RHCE gene of Hans, Xinjiang's Uigurs and Kazakstans in China, and to compare the results of RHCE genotyping with that of RhCc/Ee phenotyping.
METHODSRHCE genes of 98 Hans with RhD positive and 230 Hans, 72 Uigurs and 18 Kazakstans with RhD/RHD negative were genotyped with PCR-sequence specific primer (SSP) technique.
RESULTSThe results of RHE/RHe genotyping from samples with RhD positive and negative were in accord with that of phenotyping. It would result in 4.44% error using C-->G polymorphism at nt48 of RHCE gene to genotype RHCE, and 4.05% failure of detection using the 109 bp insertion to detectRHCE gene in Chinese Hans. The results of RHE/RHe genotyping in unrelated 72 Uigurs and 18 Kazakstans with RhD phenotype were consistent with that of phenotyping, and false positive and false negative were not found in genotyping in Uigurs and Kazakstans tested.
CONCLUSIONThe results of RHE/RHe and RHc genotyping were correct with PCR-SSP and accordant with that of phenotyping. Using the C48G polymorphism in exon 1 of RHCE to genotype RHC gene would result in false positive resulting from RHc mutation at this locus, and using the 109 bp insertion to genotype RHC gene would result in false negative because of the absence of the 109 bp. Therefore it is necessary to genotype RHC gene using more than two polymorphic loci.
Ethnic Groups ; genetics ; Genotype ; Humans ; Phenotype ; Polymorphism, Genetic ; Rh-Hr Blood-Group System ; blood ; genetics ; Serologic Tests ; methods
6.Vasorelaxing role of vasonatrin peptide in human intramammary artery in vitro.
Jun YU ; Miao-Zhang ZHU ; Geng-Ze WEI ; Bao-Ying CHEN ; Shun-Yan LU ; Yun-Fan KANG ; Hai-Tao GUO ; Heng MA ; Ming-Qing DONG
Acta Physiologica Sinica 2003;55(2):187-190
The purpose of this study was to investigate the vasorelaxing effect of vasonatrin peptide (VNP) on human intramammary artery (HIMA).The vasorelaxing effect of VNP on HIMA was measured by means of perfusion in vitro. The effects of HS-142-1, TEA, 8-Br-cGMP and methylene blue (MB) were also observed. It was found that VNP caused a concentration-dependent relaxation in HIMA which was independent of the endothelium. 8-Br-cGMP (0.1-1000 micromol/L) also caused a concentration-dependent relaxation in HIMA. The vasorelaxing effect of VNP disappeared in the presence of HS-142-1 (20 micromol/L), an antagonist of the natriuretic peptide guanylate cyclase (GC) receptor. MB (10 micromol/L), an inhibitor of GC, not only blocked completely the relaxation of HIMA, but also enhanced the vascular contraction induced by norepinephrine. TEA (1 mmol/L), an antagonist of calcium activated potassium channels (K(Ca)), reduced but not completely blocked the vasorelaxing effect of VNP. These findings suggest that VNP can relax HIMA, which is independent of the endothelium. This effect is possibly achieved by the binding of VNP with the natriuretic peptide GC receptors in the smooth muscle cells (SMCs), leading to an increase in intracellular cGMP level. Moreover, the vasorelaxing effect of VNP is associated with K(Ca).
Aged
;
Atrial Natriuretic Factor
;
pharmacology
;
Dose-Response Relationship, Drug
;
Humans
;
In Vitro Techniques
;
Mammary Arteries
;
drug effects
;
physiology
;
Middle Aged
;
Potassium Channels, Calcium-Activated
;
metabolism
;
Receptors, Guanylate Cyclase-Coupled
;
metabolism
;
Vasodilation
;
drug effects
;
physiology
7.Determination of human RHD gene rhesus box and its significance.
Hua-You ZHOU ; Jiong-Cai LAN ; Xiao-Zhu WANG ; Hong FAN ; Yi WANG ; Qing-Bao MENG ; Xiang-Sheng ZHAO ; Yin-Ze ZHANG
Journal of Experimental Hematology 2005;13(1):130-134
The aim was to determine RHD zygosity, further to investigate genetic structure of RHD gene, and to predict hemolytic disease of newborn (HDN). The upstream box, downstream box, and hybrid box of RHD gene were determined by PCR-SSP with 4 primers under the same conditions. The results showed that only hybrid box could be determined in RHD(-)/RHD(-) homozygosity. All the upstream box, downstream box, and hybrid box could be determined in RHD(+)/RHD(-) heterozygosity, while upstream box and downstream box except hybrid box could be determined in RHD(+)/RHD(+) homozygosity. Out of 50 cases of RhD(+), 5 cases (10%) were RHD(+)/RHD(-) heterozygosity, and the others (90%) were RHD(+)/RHD(+) homozygosity. 54 cases (55.1%), 36 cases (36.7%) and 8 cases (8.2%) were RHD(-)/RHD(-) homozygosity, RHD(+)/RHD(-) heterozygosity, and RHD(+)/RHD(+) homozygosity respectively in 98 unrelated cases of RhD(-) Chinese Hans. 2 cases of weak D were proved to be RHD(+)/RHD(-) heterozygosity. Out of 16 D(el) types, the upstream box, downstream box, and hybrid box could be determined in 10 cases (37.5%) and the upstream box and downstream box except hybrid box could be determined in 6 cases. Results detecting of RHD 10 exons in above samples proved the correctness of the method. It is concluded that the method is suitable for clinical application with its simplicity and veracity. There are many noneffective RHD genes (44.9%) in Chinese Hans with RhD(-) phenotype.
Genotype
;
Humans
;
Phenotype
;
Polymerase Chain Reaction
;
Polymorphism, Single Nucleotide
;
Polymorphism, Single-Stranded Conformational
;
Recombinant Fusion Proteins
;
genetics
;
Rh-Hr Blood-Group System
;
genetics
8.Purging effects of CD3AK/iNOS in vitro on primary leukemic cells from chronic myeloid leukemia patients.
Qing CHEN ; Bao-An CHEN ; Min-Sheng ZHU ; Liang-Jun ZHU ; Juan DU ; Jun WANG ; Jian CHENG ; Gang ZHAO ; Jia-Hua DING ; Yun-Yu SUN ; Ze-Ye SHAO
Journal of Experimental Hematology 2005;13(6):937-942
To investigate the purging effect of CD3AK/iNOS on primary leukemic cells from chronic myeloid leukemia patients in vitro, amphotropic packaging cell line PA317 transfected with the whole length of iNOS gene was cultivated, amplified and screened by G418. The viral titer was determined by the NIH3T3 cells. Human peripheral blood mononuclear cells were isolated and activated by anti-CD3 monoclonal antibody in vitro. CD3AK cells were incubated with viral supernatant and selected by G418. Resistant clones were assayed for iNOS gene expression by RT-RCR. The content of nitric oxide and the activity of iNOS in the culture supernatant of CD3AK/iNOS were evaluated by the method of Griess. After BMMNC or PBMNC from CML patients were co-cultured with CD3AK/iNOS, CD3AK/Neo and CD3AK/iNOS respectively, the expression of bcr/abl fusion gene was detected by serial dilution semi-quantitative net RT-PCR assay. The results showed that anti-G418 positive packaging cell line PA317 transfected with the whole length of iNOS gene clones could stably synthesize and excrete recombinant retroviral vectors. The titer of recombinant retroviral vectors was 1.0 x 10(5) CFU/ml. After being transfected by recombinant retroviral supernatant, the iNOS cDNA was expressed in CD3AK/iNOS. The content of NO and activity of iNOS that synthesized and excreted by CD3AK/iNOS were notably increased, compared with those of CD3AK. There were statistically significant differences in NO content and iNOS activity between two groups. After BMMNC or PBMNC from CML patients were co-cultured with CD3AK/iNOS, CD3AK/Neo and CD3AK/iNOS respectively, the expression of bcr/abl fusion gene in all of them was down-regulated by serial dilution semi-quantitative RT-PCR assay. It is concluded that construction of CD3AK/iNOS can markedly increase the content of NO and the activity of iNOS, which can be more efficient in in vitro purging leukemia cells for autologous hematopoietic stem cell transplantation.
Adult
;
Aged
;
Animals
;
CD3 Complex
;
immunology
;
Cell Line
;
Cytotoxicity, Immunologic
;
Female
;
Fusion Proteins, bcr-abl
;
genetics
;
Humans
;
K562 Cells
;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
;
genetics
;
immunology
;
pathology
;
Male
;
Mice
;
Middle Aged
;
NIH 3T3 Cells
;
Nitric Oxide
;
metabolism
;
Nitric Oxide Synthase Type II
;
genetics
;
metabolism
;
RNA, Messenger
;
genetics
;
metabolism
;
Reverse Transcriptase Polymerase Chain Reaction
;
Tumor Cells, Cultured
9.Effects of glutamine induced heat shock protein 70 overexpression on atrial fibrosis and connexin43 remodeling in isoprenaline-treated rats
Hong-Gang BAO ; Wei-Ze ZHANG ; Ling MA ; Tao LI ; Fei WANG ; Yong-Qing CHEN
Chinese Journal of Cardiology 2013;41(4):320-326
Objective To explore the effects of glutamine (Gln) induced heat shock protein 70 (Hsp70) overexpression on atrial fibrosis and connexin43 remodeling in isoprenaline(ISO) treated rats and related mechanisms.Methods Forty male SD rats were randomly divided into five groups (n =8 each group):control group,DMSO group,ISO5 mg · kg-1 · d-1 group (Fibrosis group),ISO5 mg· kg-1 ·d-1 +Ala-Gln0.75 mg· kg-1 ·d-1 group(Intervention group) and ISO 5 mg·kg-1 ·d-1 +QUE 100 mg·kg-1 ·d-1 +Ala-Gln0.75 mg· kg-1 · d-1 +DMSO group(QUE group).Rats were killed after7 d.The Ang Ⅱ expression in myocardial tissue was detected by radioimmunoassay; myocardial fibrosis was observed by HE staining.Collagen volume fractions were quantified by Masson staining and as the indicators of atrial fibrosis.The expressions of Hsp70,p-JNK1/2/3,c-Jun and Cx43 were determined with immunohistochemical method.Results Ang Ⅱ content was similar between the control group[(68.51 ± 10.76) pg/L] and DMSO [(71.47±11.49) pg/L] group (P> 0.05),and significantly increased in fibrosis group[(211.25 ±49.49)pg/L],intervention group[(185.32 ± 54.85) pg/L] and QUE[(189.90 ± 42.12) pg/L] group (P < 0.01 vs.control group).Atrial fibrosis was significantly higher in the fibrosis group [(29.485 ± 9.966)%] and QUE group[(25.060 ±8.581)%] but not in the intervention group[(7.861 ± 1.867)%]compared to control group [(6.842 ± 1.674) %] and DMSO group [(7.108 ± 1.343) %].The expression of Hsp70 was similar among the control group (0.160 ± 0.023),DMSO group (0.163 ± 0.022),fibrosis group(0.166 ±0.028) and QUE(0.168 ±0.027) group (P >0.05) while significantly upregulated in the intervention group (0.215 ± 0.018) (P < 0.01 vs.control group).The expressions of p-JNK1/2/3 and c-Jun were similar between control group(0.151 ±0.016;0.163 ±0.022) and DMSO group(0.154 ±0.021 ;0.164 ± 0.024) (P > 0.05),while significantly upregulated in fibrosis group (0.202 ± 0.025 ; 0.254 ± 0.044) and QU E group (0.196 ± 0.024 ; 0.251 ± 0.027) (P < 0.01 vs.control group) but not in intervention group(0.160 ±0.025 ; 0.168 ±0.024) were not changed obviously(P >0.05 vs.control group).The content of Cx43 was similar between control group and DMSO group(0.231 ± 0.035 vs.0.220 ± 0.032,P > 0.05),and was linearly distributed in intercalated disc of the cardiomyocytes,however,the content of Cx43 was significantly reduced(P < 0.01)and the Cx43 distribution was disordered in fibrosis group(0.163 ± 0.013) and QUE group(0.165 ± 0.024),while these changes were not found in intervention group.Conclusion Glutamine could reduce the atrial fibrosis and Cx43 remodeling in isoprenaline-treated rats by up-regulating Hsp70 and inhibiting JNK signaling pathway activation through down-regulating p-JNK1/2/3 and c-Jun expression.
10.Enhancement of reversing drug resistance of K562/A02 cells to adriamycin by ultrasound-induced cavitation.
Bao-An CHEN ; Qing-Qi MENG ; Wei WU ; Feng GAO ; Ze-Ye SHAO ; Jia-Hua DING ; Chong GAO ; Xin-Chen SUN ; Hong-Yan CHENG ; Yun-Yu SUN ; Jun WANG ; Jian CHENG ; Gang ZHAO ; Hui-Hui SONG ; Wen BAO ; Yan MA ; Xue-Mei WANG
Journal of Experimental Hematology 2008;16(6):1283-1287
This study was aimed to investigate the effects of low frequency and power ultrasound combined with adriamycin on apoptosis of drug-resistant leukemia cell line K562/A02 in vitro, to find out the parameters of optimal exposure, and to explore the possible mechanism reversing drug-resistance of K562/A02 cells. The K562/A02 cells in logarithmic growth phase were used in experiments. The experiments were divided into 4 groups: group control, group adriamycin (A02) alone, group ultrasound (US) alone and group A02+US. The trypan blue dye exclusion test and MTT assay were used to determine the cell viability; Wright's staining was used to detect the apoptosis; the flow cytometry was used to analyze the drug concentration, and the scanning electron microscopy was used to observe the changes of cell surface. The results showed that the significant differences in cell viability, intracellular adriamycin concentration and changes of cell membrane were found between ultrasound-treated and untreated cells in the presence of various concentration of adriamycin. The exposure to ultrasound at 20 kHZ, 0.25 W/cm2 for 60 seconds could obviously decrease LC50 of adriamycin to K562/A02 cells, while the exposure to ultrasound at 20 kHZ, 0.05 W/cm2 for 60 seconds could kill K562/A02 cells at once. After being treated by low frequency ultrasound, the small holes with diameter about 1-2 microm in the cell surface appeared. The ultrasound increased the adriamycin concentration in the cells, accelerated the formation of apoptotic bodies, and promoted apoptosis of adriamycin-resistant cells. It is concluded that the ultrasound at optimal parameters enhances inhibitory effect of adriamycin on drug-resistant cell line, thereby reverses drug-resistance of drug-resistant cell line through sound-hole effect in tumor cells resulting from ultrasound induced cavitation.
Doxorubicin
;
pharmacology
;
Drug Resistance, Multiple
;
Drug Resistance, Neoplasm
;
Humans
;
K562 Cells
;
Ultrasonics